PACB
Next earnings: Aug 3, 2026
Signal
Leaning Bearish12
Price
1
Move-7.44%Selling pressure
Volume
1
Volume1.5× avgHeavy volume
Technical
1
RSIRSI 36Momentum negative
PRICE
Prev Close
1.21
Open
1.20
Day Range1.12 – 1.21
1.12
1.21
52W Range0.85 – 2.73
0.85
2.73
14% of range
VOLUME & SIZE
Avg Volume
6.0M
FUNDAMENTALS
P/E Ratio
-2.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
2.74
High vol
Performance
1D
-4.72%
5D
-20.39%
1M
-22.93%
3M
-29.24%
6M
-24.84%
YTD
-35.29%
1Y
+10.00%
Best: 1Y (+10.00%)Worst: YTD (-35.29%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +5% YoY
Valuation
FAIR
P/E not available
Health
WEAK
CR 5.7 · FCF negative
Neutral
Key MetricsTTM
Market Cap$347.87M
Revenue TTM$160.03M
Net Income TTM-$128.58M
Free Cash Flow-$116.21M
Gross Margin37.1%
Net Margin-80.3%
Operating Margin-101.7%
Return on Equity-488.4%
Return on Assets-16.4%
Debt / Equity297.29
Current Ratio5.65
EPS TTM$-0.42

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong5 concern
21/100
Liquidity
5.65Strong
Leverage
297.29Concern
Coverage
-46.8xConcern
ROE
-488.4%Concern
ROIC
-22.7%Concern
Cash
$64MConcern
ANALYST COVERAGE18 analysts
HOLD
-10.7%downside to target
Buy
950%
Hold
844%
Sell
16%
9 Buy (50%)8 Hold (44%)1 Sell (6%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
RSI RangeRSI 36 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 5.65 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 17, 2026
In 92 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 13.4%

-22.8% vs SMA 50 · -33.2% vs SMA 200

Momentum

RSI35.9
Momentum fading
MACD-0.07
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$2.73+143.7%
EMA 200
$1.56+39.4%
EMA 50
$1.51+35.2%
Current
$1.12
52W Low
$0.8500-24.1%
52-Week RangeNear 52-week low
$0.850014th %ile$2.73
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:2
Dist days:8
Edge:+6 dist
Volume Context
Avg Vol (50D)6.1M
Recent Vol (5D)
7.1M+16%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$158.4M
$158.0M$158.8M
-$1.85
±3%
High5
FY2026(current)
$168.4M
$163.4M$173.4M
+6.3%-$0.41
±3%
High5
FY2027
$192.6M
$191.9M$193.2M
+14.3%-$0.47
±3%
High5
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 5 consecutive quarters
Earnings HistoryPACB
Last 8Q
+19.6%avg beat
Beat 6 of 8 quarters Estimates rising
+17%
Q3'24
Q4'24
Q1'25
+21%
Q2'25
+28%
Q3'25
+25%
Q4'25
+37%
Q1'26
+29%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Goldman SachsNeutral
Apr 18
DOWNGRADE
UBSBuy
Nov 17
UPGRADE
Cantor FitzgeraldOverweight
Oct 31
UPGRADE
Cowen & Co.Outperform
Mar 31
UPGRADE
Zacks Investment Re…Sell
Apr 26
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Gibson James R IiSee Remarks
$121K
Apr 1
SELL
Henry Christian OSee Remarks
$19K
Mar 3
SELL
Van Oene MarkSee Remarks
$10K
Mar 3
SELL
Farmer MicheleSee Remarks
$5K
Mar 3
SELL
Van Oene MarkSee Remarks
$205K
Feb 17
SELL
Van Oene MarkSee Remarks
$90K
Feb 18
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
ARK Investment Management LLC
36.3M
2
BlackRock, Inc.
25.3M
3
SOFTBANK GROUP CORP.
20.5M
4
Sumitomo Mitsui Trust Holdings, Inc.
7.0M
5
Nikko Asset Management Americas, Inc.
7.0M
6
GEODE CAPITAL MANAGEMENT, LLC
7.0M
7
STATE STREET CORP
6.1M
8
MILLENNIUM MANAGEMENT LLC
4.9M
News & Activity

PACB News

About

Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Industry
Analytical Laboratory Instrument Manufacturing
James R. GibsonCFO & Principal Accounting Officer
Christian O. HenryPresident, Chief Executive Officer & Director
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
PACB
$1.12-4.72%$348M+389.0%-34147.4%1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.30%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-3.22%50.3+341905.4%-8380.1%1500